Molecular Detection Inks Benelux Distribution Deal | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular Detection today said that it has signed an agreement with Dutch firm Westburg BV to be the exclusive distributor of the firm's Detect-Ready MRSA panel in the Benelux region.

The Wayne, Pa.-based firm also said that the real-time PCR-based test has been CE-Marked for detection of both methicillin-resistant Staphylococcus aureus and methicillin-sensitive S, aureus. It said that the screening test enables physicians to distinguish the two types of infections.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.